Hearing Loss Trial, Recruiting NCT06860152 Sponsor: Craig D. Workman, PhD Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06860152
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with a cochlear implant (up to 120 participants):

  • Adults aged 18 to 99 years old
  • People whose cochlear implant has been switched on and in use for more than one year
  • People who meet the research eligibility requirements of the Iowa Cochlear Implant Project VIII (confirm with trial site)
  • People who are able to understand the study information and are willing to sign a consent form
  • People who developed severe hearing loss after the age of 16

For people with normal hearing (up to 30 participants):

  • Adults aged 18 to 99 years old
  • People whose hearing is typical for their age
  • People who meet the research eligibility requirements of the Iowa Cochlear Implant Project VIII (confirm with trial site)
  • People who are able to understand the study information and are willing to sign a consent form

Who may not be able to join:

  • People with a medical history that includes seizures, head injury, neurological conditions, metabolic conditions, heart or blood vessel disease, or a previous stroke — unless the principal investigator approves their participation
  • People who are currently pregnant or who report being pregnant (a urine pregnancy test will be done before a study injection is given)
  • People who are currently taking medications that may affect blood flow to the brain, such as papaverine, ginkgo biloba, or acetazolamide
  • People with an ongoing or uncontrolled illness that the investigator believes would make it difficult to participate fully in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Craig D. Workman, PhD, University of Iowa

Phone: (319) 384-5468

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Craig D. Workman, PhD
Registry
ClinicalTrials.gov
Start date
14 November 2024
Est. completion
31 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

To identify the cortical bases for speech-in-noise understanding in cochlear implant users

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov